Consequences of implementation of HPV screening for cervical cancer
Monday, October 9, 2017
•
MSS 04
•
4:15 PM
>
5:45 PM
•
Consequences of implementation of HPV screening for cervical cancer
•
Auditorium
•
MSS 04-01
•
1. Impact of change from cytology to molecular biology
See abstract
>
E.
Eduardo
Franco
•
MSS 04-02
•
2. The Europeans experiences of implementation of HPV screening for CC: performance of triage cytology and implications for the management of HPV positive women
See abstract
>
N.
Nynke
VAN DER VEEN
•
MSS 04-03
•
Implementation of HPV screening: situation in Germany
>
P.
Peter
HILLEMANNS
•
MSS 04-04
•
4. What's happening in the second round?
See abstract
>
F.
Francesca
CAROZZI
•
MSS 04-05
•
5. Quality assurance programs for HPV and cytology related screening and the implication for laboratory organization
See abstract
>
M.
Mario
POLJAK
•
MSS 04-06
•
Development and evaluation of new triage markers
See abstract
>
N.
Nicolas
Wentzensen
|